Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns

Extramedullary disease (EMD) represents a high-risk state of multiple myeloma (MM) associated with poor prognosis. While most anti-myeloma therapeutics demonstrate limited efficacy in this setting, some studies exploring the utility of chimeric antigen receptor (CAR)-modified T cells reported promis...

Descripción completa

Detalles Bibliográficos
Autores principales: Danhof, Sophia, Rasche, Leo, Mottok, Anja, Steinmüller, Tabea, Zhou, Xiang, Schreder, Martin, Kilian, Teresa, Strifler, Susanne, Rosenwald, Andreas, Hudecek, Michael, Einsele, Hermann, Gerhard-Hartmann, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116297/
https://www.ncbi.nlm.nih.gov/pubmed/33575947
http://dx.doi.org/10.1007/s00277-021-04447-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116297/
https://www.ncbi.nlm.nih.gov/pubmed/33575947
http://dx.doi.org/10.1007/s00277-021-04447-6

Ejemplares similares